Our Investors
Join Pharmos and other Pharmos Corp subdivisions. We already have support from many private and public organizations within the region and outside. They support us with investments for new researches, initiatives, and projects. Join us and benefit from the following:
- Regular invitations to the board of directors meetings;
- Full participation in Pharmos committees;
- Privileged access to the events held by Pharmos Corp and its branches;
- Private communication with the speakers;
- Interactive access to the Pharmos website if you’re willing to keep track of the progress;
- Official sanction to host events and meetings;
- Comprehensive information about the innovative products and services;
- Link to your organization on the official Pharmos webpage.
If your private or public company wants to be among our respected investors, you’ll have to participate in some of Pharmos’s activities and programs, so that our customers could regard you as a reliable and initiative partner. Your investment level depends on the size of the organization.
Our Top Private and Public Investors
Established in 1996 and headquartered in Basel, Switzerland, the company invests in biotechnology, life sciences, digital health, and oncology treatment. The American office is situated in Cambridge, Massachusetts.
Established in 2012 and is headquartered in Menlo Park, California. The company deals with regenerative medicine based on pluripotency. It uses stem cells for replacement therapy to discover and treat cancer, acute injuries, and neurology. Now, it is a part of BioTime that also involves regenerative medicine to test products in oncological, neurological, and body injury therapies.
Established in 2002 and headquartered in Singapore, the agency aims at fighting and preventing pollution, maintaining public health, and providing information about climate changes and meteorological issues.
A Global Biopharmaceutical Company established in 1887 and headquartered in Clinton, New York, United States. The company is involved in numerous issues concerning therapeutic activities, including cancer and HIV/AIDS treatment, psychiatric disorders, diabetes, cardiovascular condition, hepatitis, diabetes, and rheumatoid arthritis.
An immuno-oncology company, established in 2003 and headquartered in the Netherlands. They are a dedicated team of specialists passionate about their fight with cancer. Their antibody therapeutics are efficient against several cancer types.
Established in 1989 and headquartered in Panchkula, Haryana, India, this company is known for its R&D initiatives. It’s a pharmaceutical manufacturing company providing efficient formulations for oncological supportive therapies and anti-biotics. Some of the departments are now located in Germany.